Government Shields Makers of Andes Virus Treatments
Published Date: 5/27/2026
Notice
Summary
The government is protecting doctors, nurses, and companies who make or use medicines to fight Andes virus, a rare but serious lung disease spread mainly in South America. This protection means they won’t be sued for most problems related to these medicines, starting right now. This helps speed up efforts to keep people safe without worrying about legal troubles.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 1 costs, 1 mixed.
Legal Immunity for Makers and Providers
The Declaration gives liability immunity to "Covered Persons" (manufacturers, distributors, program planners, qualified persons, and the United States) for manufacture, testing, development, distribution, and voluntary administration of the covered countermeasure (favipiravir) related to Andes virus exposures. Immunity is in effect as of the date of signature and extends through July 18, 2026, plus one additional month for disposition activities.
Patients' Limits on Suing for Injuries
If you receive the covered countermeasure (favipiravir) in accordance with this Declaration, most claims for loss against manufacturers or providers are precluded—negligence claims are barred except for claims involving "willful misconduct." This limitation on lawsuits applies without geographic limitation and is in effect through July 18, 2026 (plus one month).
Countermeasures Injury Compensation Program Rules
The Countermeasures Injury Compensation Program (CICP) may provide benefits to individuals who sustain a serious physical injury or die as a direct result of a covered countermeasure, but causation must be shown with "compelling, reliable, valid, medical and scientific evidence." For countermeasures given outside the U.S., only otherwise eligible individuals at U.S. embassies, military installations abroad, or NATO installations may be considered for CICP benefits.
Covered Countermeasure and Distribution Limits
The Declaration identifies favipiravir as the Covered Countermeasure and limits liability immunity to Recommended Activities involving countermeasures obtained for voluntary administration in accordance with an approved IND application. For governmental program planners, immunity applies only when countermeasures are obtained through voluntary means (donation, commercial sale, federal stockpile deployment, or state/local/private stockpiles).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10292 — Medicaid Program; Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments
This proposed rule changes how states can pay Medicaid managed care plans and certain doctors to make sure payments are fair, efficient, and encourage enough providers to offer quality care. It affects states, Medicaid managed care organizations, and targeted Medicaid practitioners, aiming to keep payments balanced and services available. Comments on these changes are open until July 21, 2026, so stakeholders have time to weigh in before it’s finalized.
2026-10050 — Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program
Starting in 2027, health insurance plans on federal and state marketplaces will see new rules to make coverage fairer and easier to use. These changes affect insurance companies, agents, and people buying plans, including new fees, penalties, and better protections for those with hardships. Expect updates on plan quality, dental coverage limits, and longer-term catastrophic plans, all aiming to keep your health coverage solid and affordable.
2026-09383 — Restoring Flexibility To Support Head Start Program Access
The government wants to give Head Start programs more freedom by removing some strict rules about staff wages and benefits. This change aims to save over $2 billion and help programs serve more kids better. If you want to share your thoughts, make sure to comment by June 11, 2026!
2026-09382 — Restoring Flexibility in the Child Care and Development Fund (CCDF)
Starting July 13, 2026, states and territories get more freedom in running the Child Care and Development Fund (CCDF). This means they no longer have to limit family co-pays to 7% of income or follow strict rules on paying child care providers. These changes cut red tape and could save money, making it easier to support families and child care programs.
2026-07205 — Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges
This new rule will help Medicare, Medicaid, CHIP, and health plan companies share patient info more easily and speed up drug approval requests. It affects Medicare Advantage, Medicaid, CHIP, and health plans on federal exchanges, aiming to make care smoother and faster. These changes will start soon and could save time and money by cutting red tape.
2026-06632 — Work Participation Rate Calculation Changes: Recalibration of the Caseload Reduction Credit and Prohibition of Small Checks in Work Participation Rate Calculation
The government is updating how it measures work participation for families getting help through TANF. They’re changing the base year for counting caseload drops from 2005 to 2015 and won’t count tiny monthly payments under $35 in work rate calculations. These changes, required by a 2023 law, affect states and could impact funding starting soon, so everyone should pay attention and share their thoughts by May 6, 2026.
Previous / Next Documents
Previous: 2026-10535 — Notice of Decision on Innovative Product Exemption Applications Under the National Volatile Organic Compound Emission Standards for Consumer Products
The EPA has decided on two special requests from Henkel and PLZ to let their hairsprays have more VOCs than usually allowed, because their products still keep pollution low. This means these companies can sell their innovative hairsprays without breaking the rules starting May 27, 2026. If you make or sell similar products, keep an eye on these changes—they could affect your business and the environment!
Next: 2026-10543 — Control of Communicable Diseases; Foreign Quarantine
Starting May 22, 2026, the CDC can temporarily stop people from certain countries from entering the U.S. to protect public health. This new rule affects travelers and border officials and stays in effect for up to six months unless extended or ended sooner. The CDC wants your feedback by June 26, 2026, so jump in and share your thoughts!